Cite
HARVARD Citation
Tack, J. et al. (2016). Randomized clinical trial: a controlled pilot trial of the 5‐HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis. Neurogastroenterology & motility. 28 (4), pp. 487-497. [Online].